No Data
No Data
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Haoyuan Pharmaceutical (688131.SH) disclosed the results of the convertible bonds lottery: there are a total of 0.2674 million winning numbers.
On December 1st, Gelonghui reported that Haoyuan Pharmaceutical (688131.SH) announced the results of the online lottery for the issuance of convertible corporate bonds to unspecified objects, and the lottery results are as follows: Investors participating in the online subscription of Haoyuan convertible bonds whose subscription allocation number ending matches the above numbers will be considered as winning numbers. There are a total of 267,408 winning numbers, and each winning number can only subscribe for 1 lot (1,000 yuan) of Haoyuan convertible bonds.
Haoyuan Pharmaceutical (688131.SH): "Haoyuan Convertible Bonds" will open for subscription on November 28th.
Haoyuan Medicine (688131.SH) announced that the company's convertible bonds issued this time are referred to as 'Haoyuan Convertible...'.
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 36% Price Boost Is Out Of Tune With Earnings
Shanghai Haoyuan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Haoyuan Pharmaceutical (688131.SH): the net income in the first three quarters was 0.143 billion yuan, with a year-on-year growth of 21.31%.
On October 29th, Haoyuan Medicine (688131.SH) announced that in the first three quarters of 2024, it achieved total operating income of 1.619 billion yuan, an increase of 17.65% year-on-year; the net income attributable to the parent company's shareholders was 0.143 billion yuan, a year-on-year increase of 21.31%; and the basic earnings per share was 0.68 yuan.